Report on Psychedelics

In the RoP Briefing for the Week of May 4th:

Orthogonal Thinker Raises $6M

Dr. Bronner Extends Support of Psychedelics

Champignon Brands Partners With Pharmacy Chain

Is This The Works Press Release Yet?

Field Trip is a mental wellness company at the forefront of the scientific re-emergence of psychedelics and psychedelic-enhanced therapies. Through its subsidiary Field Trip Health, they operate psychedelic enhance therapy clinics, the first in downtown Toronto and through Field Trip Discovery, they are conducting advanced research on plant-based psychedelics.

RoP spoke with Ronan Levy the Executive Chairman of Field Trip, we discussed the company's founding, its unique patient experience, what separates them from the competition, and their path ahead.

In The RoP Briefing for the Week of April 27th:

ATAI Raises $24M

CB Therapeutics Partners with Cleveland Clinic

MindMed Patents LSD Off Switch

Video Game Seeks to Create Psychedelic Experience

In the RoP Briefing for the week of April 20th:

Australians Push for Psychedelic Access

Study Shines New Light On Psilocybin and The Brain

DC Decrim Effort Continues Through Obstacles

Canadian Petition For Psychedelic Decrim

MindMed Takes The Next Step in Moving 18-MC Trials Forward

In the RoP Briefing for the week of April 13:

Field Trip Psychedelics launches drug discovery division

A new study finds long lasting effects of psilocybin

Champignon Brands to acquire Altmed Capital Corp

MAPS partially halts clinical trials amid Covid-19

Calls for psychedelic approval to treat Covid-19 side effects

In the RoP Briefing for the week of April 6th:

MindMed Acquires LSD Clinic Trials

Native American Groups Mobilize Against Peyote Decriminalization

Scientists Are Redesigning Magic Mushrooms To Eliminate Bad Trips

Is Corona virus isolation a good excuse to trip?

The Goop for Psychedelics

In the RoP Briefing for the week of March 30th:

Calls for ketamine therapy to be declared an essential service

Mindmed Advances 18-MC clinical testing

Seelos Therapeutics announces interim data from ketamine study

The Denver Psilocybin Mushroom Policy Review Panel meets again

Oregon psychedelic legalization ballot measure disrupted

In the RoP Briefing for the week of March 23rd:

Covid-19 Expected To Delay Clinical Trials

Mindbloom Launches Online Ketamine Therapy

How To Trip Without Drugs

Dosed Movie Misses The Mark

In the RoP Briefing for the week of March 16th:

Psychedelic Medicine Lands On Fifth Avenue

Salvation Biosciences Completes $6M Financing

Psychedelic Therapy Clinics Aren’t Exactly New

What We Know About How Ketamine Works

DC Presses Pause on Decrim Efforts

In this week’s Briefing:

First Israeli patients complete MDMA trial

Field Trip Health opens psychedelic clinic

Therapists get a psychedelic education

Warnings of a sexual abuse problem in psychedelic therapy

What happens when you take way too much LSD